Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors

Takanori Teshima, Keitaro Matsuo, Kosei Matsue, Fumio Kawano, Shuichi Taniguchi, Masamichi Hara, Kazuo Hatanaka, Mitsune Tanimoto, Mine Harada, Shinji Nakao, Yasunobu Abe, Atsushi Wake, Tetsuya Eto, Yoshinobu Takemoto, Masahiro Imamura, Satoshi Takahashi, Yoji Ishida, Yoshinobu Kanda, Masaharu Kasai, Yoichi Takaue

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The impact of human leucocyte antigen (HLA) incompatibility between donor and recipient on graft-versus-host disease (GVHD) and graft failure after reduced-intensity conditioning stem cell transplantation (RICT) remains to be elucidated. We retrospectively analysed outcome in 341 patients who underwent RICT from related donors for haematological malignancies. The overall cumulative incidence of grade II-IV acute GVHD (aGVHD) was 40% for all subjects; 39% in recipients with HLA-matched donors, 44% in those with one-locus-mismatched donors, and 50% in those with two- to three-loci-mismatched donors. In a Cox regression model adjusted for potential confounders, the tendency for grade II-IV aGVHD (P = 0·01), chronic GVHD (cGVHD) (P = 0·05) and graft failure (P = 0·033) increased with HLA disparity. Use of peripheral blood grafts instead of marrow was a risk factor for cGVHD. Use of antithymocyte globulin was associated with reduced aGVHD and cGVHD. Overall survival (OS) in recipients of two- to three-loci-mismatched RICT at 2 years (18%) was significantly worse than that in patients who received one-locus-mismatched RICT (51%) and HLA-matched RICT (48%) (P <0·0001). A two- to three-loci mismatch was identified as an independent risk factor for OS (P <0·001), but there was no significant difference in OS between HLA-matched and one-locus-mismatched RICT. HLA incompatibility between the donor and recipient is an important risk factor for graft failure, aGVHD, cGVHD and OS after RICT. RICT from a one-locus-mismatched donor may represent an effective alternative approach in patients with high-risk malignancies who lack HLA-matched related donors.

Original languageEnglish
Pages (from-to)575-587
Number of pages13
JournalBritish Journal of Haematology
Volume130
Issue number4
DOIs
Publication statusPublished - Aug 2005

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
HLA Antigens
Tissue Donors
Transplants
Survival
Antilymphocyte Serum
Stem Cell Transplantation
Hematologic Neoplasms
Proportional Hazards Models
Bone Marrow
Incidence

Keywords

  • Antithymocyte globulin
  • Graft-versus-host disease
  • Human leucocyte antigen
  • Reduced intensity conditioning
  • Rejection

ASJC Scopus subject areas

  • Hematology

Cite this

Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. / Teshima, Takanori; Matsuo, Keitaro; Matsue, Kosei; Kawano, Fumio; Taniguchi, Shuichi; Hara, Masamichi; Hatanaka, Kazuo; Tanimoto, Mitsune; Harada, Mine; Nakao, Shinji; Abe, Yasunobu; Wake, Atsushi; Eto, Tetsuya; Takemoto, Yoshinobu; Imamura, Masahiro; Takahashi, Satoshi; Ishida, Yoji; Kanda, Yoshinobu; Kasai, Masaharu; Takaue, Yoichi.

In: British Journal of Haematology, Vol. 130, No. 4, 08.2005, p. 575-587.

Research output: Contribution to journalArticle

Teshima, T, Matsuo, K, Matsue, K, Kawano, F, Taniguchi, S, Hara, M, Hatanaka, K, Tanimoto, M, Harada, M, Nakao, S, Abe, Y, Wake, A, Eto, T, Takemoto, Y, Imamura, M, Takahashi, S, Ishida, Y, Kanda, Y, Kasai, M & Takaue, Y 2005, 'Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors', British Journal of Haematology, vol. 130, no. 4, pp. 575-587. https://doi.org/10.1111/j.1365-2141.2005.05632.x
Teshima, Takanori ; Matsuo, Keitaro ; Matsue, Kosei ; Kawano, Fumio ; Taniguchi, Shuichi ; Hara, Masamichi ; Hatanaka, Kazuo ; Tanimoto, Mitsune ; Harada, Mine ; Nakao, Shinji ; Abe, Yasunobu ; Wake, Atsushi ; Eto, Tetsuya ; Takemoto, Yoshinobu ; Imamura, Masahiro ; Takahashi, Satoshi ; Ishida, Yoji ; Kanda, Yoshinobu ; Kasai, Masaharu ; Takaue, Yoichi. / Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. In: British Journal of Haematology. 2005 ; Vol. 130, No. 4. pp. 575-587.
@article{5ea17cc6792c435c98a8e0e9e20231f7,
title = "Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors",
abstract = "The impact of human leucocyte antigen (HLA) incompatibility between donor and recipient on graft-versus-host disease (GVHD) and graft failure after reduced-intensity conditioning stem cell transplantation (RICT) remains to be elucidated. We retrospectively analysed outcome in 341 patients who underwent RICT from related donors for haematological malignancies. The overall cumulative incidence of grade II-IV acute GVHD (aGVHD) was 40{\%} for all subjects; 39{\%} in recipients with HLA-matched donors, 44{\%} in those with one-locus-mismatched donors, and 50{\%} in those with two- to three-loci-mismatched donors. In a Cox regression model adjusted for potential confounders, the tendency for grade II-IV aGVHD (P = 0·01), chronic GVHD (cGVHD) (P = 0·05) and graft failure (P = 0·033) increased with HLA disparity. Use of peripheral blood grafts instead of marrow was a risk factor for cGVHD. Use of antithymocyte globulin was associated with reduced aGVHD and cGVHD. Overall survival (OS) in recipients of two- to three-loci-mismatched RICT at 2 years (18{\%}) was significantly worse than that in patients who received one-locus-mismatched RICT (51{\%}) and HLA-matched RICT (48{\%}) (P <0·0001). A two- to three-loci mismatch was identified as an independent risk factor for OS (P <0·001), but there was no significant difference in OS between HLA-matched and one-locus-mismatched RICT. HLA incompatibility between the donor and recipient is an important risk factor for graft failure, aGVHD, cGVHD and OS after RICT. RICT from a one-locus-mismatched donor may represent an effective alternative approach in patients with high-risk malignancies who lack HLA-matched related donors.",
keywords = "Antithymocyte globulin, Graft-versus-host disease, Human leucocyte antigen, Reduced intensity conditioning, Rejection",
author = "Takanori Teshima and Keitaro Matsuo and Kosei Matsue and Fumio Kawano and Shuichi Taniguchi and Masamichi Hara and Kazuo Hatanaka and Mitsune Tanimoto and Mine Harada and Shinji Nakao and Yasunobu Abe and Atsushi Wake and Tetsuya Eto and Yoshinobu Takemoto and Masahiro Imamura and Satoshi Takahashi and Yoji Ishida and Yoshinobu Kanda and Masaharu Kasai and Yoichi Takaue",
year = "2005",
month = "8",
doi = "10.1111/j.1365-2141.2005.05632.x",
language = "English",
volume = "130",
pages = "575--587",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors

AU - Teshima, Takanori

AU - Matsuo, Keitaro

AU - Matsue, Kosei

AU - Kawano, Fumio

AU - Taniguchi, Shuichi

AU - Hara, Masamichi

AU - Hatanaka, Kazuo

AU - Tanimoto, Mitsune

AU - Harada, Mine

AU - Nakao, Shinji

AU - Abe, Yasunobu

AU - Wake, Atsushi

AU - Eto, Tetsuya

AU - Takemoto, Yoshinobu

AU - Imamura, Masahiro

AU - Takahashi, Satoshi

AU - Ishida, Yoji

AU - Kanda, Yoshinobu

AU - Kasai, Masaharu

AU - Takaue, Yoichi

PY - 2005/8

Y1 - 2005/8

N2 - The impact of human leucocyte antigen (HLA) incompatibility between donor and recipient on graft-versus-host disease (GVHD) and graft failure after reduced-intensity conditioning stem cell transplantation (RICT) remains to be elucidated. We retrospectively analysed outcome in 341 patients who underwent RICT from related donors for haematological malignancies. The overall cumulative incidence of grade II-IV acute GVHD (aGVHD) was 40% for all subjects; 39% in recipients with HLA-matched donors, 44% in those with one-locus-mismatched donors, and 50% in those with two- to three-loci-mismatched donors. In a Cox regression model adjusted for potential confounders, the tendency for grade II-IV aGVHD (P = 0·01), chronic GVHD (cGVHD) (P = 0·05) and graft failure (P = 0·033) increased with HLA disparity. Use of peripheral blood grafts instead of marrow was a risk factor for cGVHD. Use of antithymocyte globulin was associated with reduced aGVHD and cGVHD. Overall survival (OS) in recipients of two- to three-loci-mismatched RICT at 2 years (18%) was significantly worse than that in patients who received one-locus-mismatched RICT (51%) and HLA-matched RICT (48%) (P <0·0001). A two- to three-loci mismatch was identified as an independent risk factor for OS (P <0·001), but there was no significant difference in OS between HLA-matched and one-locus-mismatched RICT. HLA incompatibility between the donor and recipient is an important risk factor for graft failure, aGVHD, cGVHD and OS after RICT. RICT from a one-locus-mismatched donor may represent an effective alternative approach in patients with high-risk malignancies who lack HLA-matched related donors.

AB - The impact of human leucocyte antigen (HLA) incompatibility between donor and recipient on graft-versus-host disease (GVHD) and graft failure after reduced-intensity conditioning stem cell transplantation (RICT) remains to be elucidated. We retrospectively analysed outcome in 341 patients who underwent RICT from related donors for haematological malignancies. The overall cumulative incidence of grade II-IV acute GVHD (aGVHD) was 40% for all subjects; 39% in recipients with HLA-matched donors, 44% in those with one-locus-mismatched donors, and 50% in those with two- to three-loci-mismatched donors. In a Cox regression model adjusted for potential confounders, the tendency for grade II-IV aGVHD (P = 0·01), chronic GVHD (cGVHD) (P = 0·05) and graft failure (P = 0·033) increased with HLA disparity. Use of peripheral blood grafts instead of marrow was a risk factor for cGVHD. Use of antithymocyte globulin was associated with reduced aGVHD and cGVHD. Overall survival (OS) in recipients of two- to three-loci-mismatched RICT at 2 years (18%) was significantly worse than that in patients who received one-locus-mismatched RICT (51%) and HLA-matched RICT (48%) (P <0·0001). A two- to three-loci mismatch was identified as an independent risk factor for OS (P <0·001), but there was no significant difference in OS between HLA-matched and one-locus-mismatched RICT. HLA incompatibility between the donor and recipient is an important risk factor for graft failure, aGVHD, cGVHD and OS after RICT. RICT from a one-locus-mismatched donor may represent an effective alternative approach in patients with high-risk malignancies who lack HLA-matched related donors.

KW - Antithymocyte globulin

KW - Graft-versus-host disease

KW - Human leucocyte antigen

KW - Reduced intensity conditioning

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=24944529200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944529200&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2005.05632.x

DO - 10.1111/j.1365-2141.2005.05632.x

M3 - Article

C2 - 16098073

AN - SCOPUS:24944529200

VL - 130

SP - 575

EP - 587

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -